GRAIL, Inc. Depreciation
GRAIL, Inc. (GRAL) reported Depreciation of $8.31 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-08-06
- GRAIL, Inc. depreciation for the quarter ending 2026-06-30 was $4.11M, a 10.61% decline year-over-year.
- GRAIL, Inc. depreciation for the quarter ending 2026-03-31 was $4.21M, a 10.33% decline year-over-year.
- GRAIL, Inc. depreciation for the quarter ending 2025-12-31 was $4.32M, a 10.99% decline year-over-year.
- GRAIL, Inc. depreciation for the quarter ending 2025-09-30 was $4.40M, a 5.34% decline year-over-year.
- GRAIL, Inc. depreciation for fiscal 2025 was $18.01M, a 8.69% decline from fiscal 2024.
- GRAIL, Inc. depreciation for fiscal 2024 was $19.72M, a 3.15% decline from fiscal 2023.
- GRAIL, Inc. depreciation for fiscal 2023 was $20.36M, a 23.94% increase from fiscal 2023.
- GRAIL, Inc. depreciation for fiscal 2023 was $16.43M.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|
| 2026-06-30 | $4.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $8.31M 10-Q · filed 2026-08-06 | $12.64M derived: sum of 3 quarters · filed 2026-08-06 | $17.04M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $4.21M 10-Q · filed 2026-05-07 | $8.53M derived: sum of 2 quarters · filed 2026-05-07 | $12.93M derived: sum of 3 quarters · filed 2026-05-07 | $17.52M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $4.32M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $8.72M derived: sum of 2 quarters · filed 2026-03-12 | $13.31M derived: sum of 3 quarters · filed 2026-08-06 | $18.01M 10-K · filed 2026-03-12 |
| 2025-09-30 | $4.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $8.99M derived: sum of 2 quarters · filed 2026-08-06 | $13.69M 10-Q · filed 2025-11-13 | $18.54M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $4.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $9.29M 10-Q · filed 2026-08-06 | $14.14M derived: sum of 3 quarters · filed 2026-08-06 | $18.79M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $4.70M 10-Q · filed 2026-05-07 | $9.55M derived: sum of 2 quarters · filed 2026-05-07 | $14.20M derived: sum of 3 quarters · filed 2026-05-07 | $19.00M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $4.86M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $9.51M derived: sum of 2 quarters · filed 2026-03-12 | $14.31M derived: sum of 3 quarters · filed 2026-03-12 | $19.72M 10-K · filed 2026-03-12 |
| 2024-09-30 | $4.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $9.45M derived: sum of 2 quarters · filed 2025-11-13 | $14.87M 10-Q · filed 2025-11-13 | $20.21M derived: sum of 4 quarters · filed 2026-03-12 |
| 2024-06-30 | $4.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $10.22M 10-Q · filed 2025-08-13 | $15.56M derived: sum of 3 quarters · filed 2026-03-12 | $20.78M derived: sum of 4 quarters · filed 2026-03-12 |
| 2024-03-31 | $5.41M 10-Q · filed 2025-05-14 | $10.76M derived: sum of 2 quarters · filed 2026-03-12 | $15.97M derived: sum of 3 quarters · filed 2026-03-12 | |
| 2023-12-31 | $5.35M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $10.56M derived: sum of 2 quarters · filed 2026-03-12 | $20.36M 10-K · filed 2025-03-05 | |
| 2023-10-01 | $5.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $15.02M 10-Q · filed 2024-11-13 | ||
| 2023-06-30 | $9.80M 10-Q · filed 2024-08-13 | |||
| 2023-01-01 | $16.43M 10-K · filed 2025-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |